Abel Hall LLC
EVH icon

Abel Hall LLC’s Evolent Health EVH Stock Holding History

Abel Hall LLC’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-14,150
Closed -$76.7K – 953
2026
Q2 		$76.7K Buy
+14,150
New +$54.3K 0.01% 866

Other funds holding EVH

Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return
Tempus Wealth Planning
Tempus Wealth Planning Irvine, California $522M AUM 17.46% 1-Year Est. Return
HB Wealth Management
HB Wealth Management Atlanta, Georgia $19.5B AUM 16.96% 1-Year Est. Return
Vise Technologies
Vise Technologies New York $12B AUM 18.78% 1-Year Est. Return
EFL
ERn Financial LLC Middleton, Wisconsin $613M AUM 12.18% 1-Year Est. Return
Harbor Capital Advisors
Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return
SignatureFD
SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Abel Hall LLC's EVH Position: Q3 2026 in Review

Abel Hall LLC sold out of Evolent Health (EVH) in Q3 2026, closing a stake of 14,150 shares — an estimated $76.7K sold.

Abel Hall LLC first reported a position in EVH in Q2 2026 and held it in 1 quarter. The position peaked at $76.7K in Q2 2026. 32 funds tracked by Wall St. Rank hold EVH as of Q3 2026.

  • Abel Hall LLC reported no remaining Evolent Health position as of Q3 2026 after selling out during the quarter.
  • Abel Hall LLC sold 14,150 Evolent Health shares in Q3 2026, an estimated $76.7K.
  • Abel Hall LLC first reported a position in Evolent Health in Q2 2026 and held it in 1 quarter.
  • Abel Hall LLC's Evolent Health position peaked at $76.7K in Q2 2026.
  • 32 funds tracked by Wall St. Rank held Evolent Health as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.